Low-dose Methotrexate Therapy for Ocular Inflammatory Disease
Authors:
- Careen Y. LowderCLCareen Y. Lowder
- Michael A. SchmittMSMichael A. Schmitt
- William S. WilkeWWWilliam S. Wilke
- Gregory S. KosmorskyGKGregory S. Kosmorsky
- David M. MeislerDMDavid M. Meisler
- 1 September 1992
- journal article
- Published by Elsevier in Ophthalmology
- Vol. 99 (9) , 1419-1423
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Antiproliferative effects of methotrexate on peripheral blood mononuclear cellsArthritis & Rheumatism, 1989
- Cyclophosphamide in the Treatment of Orbital VasculitisAmerican Journal of Ophthalmology, 1986
- Treatment of severe Graves' ophthalmopathy with cyclosporin AEuropean Journal of Endocrinology, 1985
- Management of orbital inflammatory disease. A protocolSurvey of Ophthalmology, 1984
- The nonspecific orbital inflammatory syndromesSurvey of Ophthalmology, 1984
- The Pharmacology and Clinical Use of MethotrexateNew England Journal of Medicine, 1983
- Radiotherapy for Idiopathic Inflammatory Orbital PseudotumorArchives of Ophthalmology (1950), 1981
- GLUCOCORTICOID THERAPYMedicine, 1976
- Immunosuppressive Therapy for the Eye Changes of Graves' DiseaseThe Journal of Clinical Endocrinology & Metabolism, 1970
- Immunosuppressive Effects of Cytosine Arabinoside and Methotrexate in ManAnnals of Internal Medicine, 1969